Business
Pfizer beats back variants as AstraZeneca receives a timely boost – Sydney Morning Herald
Pfizer’s vaccine seems to offer good protection against the South African variant of COVID-19, while British data has given AstraZeneca a lift, in positive news…
Its reassuring, said Professor Fiona Russell, an adviser to the World Health Organisation on vaccines, based at the Murdoch Childrens Research Institute.
Certainly, Pfizer is a great vaccine. There is no doubt about that.
However, the study is limited by the fact the researchers did not explicitly test each infected person to see if they had contracted the South African variant. They simply assumed that if they did not have the British variant they must have the South African virus.
Im not a big…
-
Noosa News23 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
Noosa News13 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
Noosa News23 hours ago‘Low morale, decreasing trust in leadership’: Top cop’s stark warning
-
General9 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call